Background: The proper evaluation of the prescribing indicators helps to curb the injudicious use of drugs. Keeping this point in mind the present study was designed and carried out in order to check the prescribing pattern in the orthopaedic outpatients using the WHO prescribing indicators in a tertiary care teaching hospital, Lucknow. Methods: Data was collected from the outpatients of the orthopaedic department relating to demographics and the drug details in a structured Performa and were subsequently analyzed in accordance with the WHO prescribing indicators. The prescriptions were further analyzed for any errors relating to the prescription writing. Values were expressed in percentages. Results: A total of 261 prescriptions were analyzed comprising 796 drugs. Out of 261 patients, 147 (56.32%) were male while 114 (43.68%) were females. Most of the patients, i.e. 137 (52.49%) belonged to the age group of 18 -60 years. Out of the total prescriptions analyzed it was found that only 37 (14.18%) had drugs prescribed by the generic names and only 115 (44.06%) prescriptions were complete in all respect. Anti-ulcer drugs were most commonly prescribed and a total of 227 (86.97%) prescriptions had them. This was followed closely by NSAIDs with or without serratiopeptidases which formed a part of 217 (83.14%) prescriptions. Polypharmacy was an area of grave concern and the average number of drugs per prescription came out to be 3.05. A total of 128 (49.04%) prescriptions had 5 drugs written in them. The signature of the treating doctor was absent in or there was an untraceable signature in 235 (90.04%) prescriptions while the stamp of the treating doctor was absent in 216 (82.76%) cases. In 146 prescriptions (55.94%) the duration of treatment was not written and the follow up advice was not clear in 195 (74.71%) cases. Conclusion:This study provides the insight to the prescribing pattern in outpatients of orthopaedic department. The results obtained clearly show an immediate need for the increased awareness among the physicians as well as the medical students towards the WHO recommended prescribing indicators.
A distinct feature of the India’s path of financial liberalization is that it led to the emergence of the corporate, non-financial sector, rather than the financial sector as the key wedge for the penetration of global finance. Neoliberal reforms eroded the traditional role of development banks and state-directed credit and empowered a section of large corporations and non-financial companies in India. The partial, calibrated path to capital account liberalization has meant that this section of the Indian non-financial corporate sector, rather than the commercial banking system came to be the conduit integrating the Indian economy with international financial markets. Where the Indian state had earlier harnessed finance towards developmental priorities, it shifted to channeling finance in service of the internationally embedded segment of the corporate sector that enjoys disproportionate access to both the domestic financial system and international financial markets.
Background: Price of a drug is an important factor for compliance to the treatment. So, to overcome the high prices of drugs, National Pharmaceutical Pricing Authority (NPPA) under government of India has issued Drug Price Control Order (DPCO) list containing commonly used drugs. Pharmaceutical companies can be punished if they keep their prices higher than the ceiling price mentioned in the DPCO. To find out the price variations of commonly used antidepressant drugs included in DPCO list of 29th April 2019.Methods: A list of all oral antidepressant drugs included in DPCO of 29th April 2019 and available in Indian market was procured from medguide India. Analysis of number of total brands following as well as not following DPCO ceiling price was done.Results: Author found 17 formulations of four antidepressant drugs included in DPCO. Total 556 brands found out of which 84.6% were following the DPCO and 15.4% of brands prices were higher than the ceiling price of DPCO.Conclusions: Though large number of companies are following the DPCO but still strict regulation is needed to further increase the compliance of guidelines.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.